SEC Form 4 · accession 0001144204-16-129414
CASI Pharmaceuticals, Inc. · CASI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wei-Wu He
Director
Period of report
Oct 24, 2016
Accepted (ET)
Oct 25, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $1.40 | Oct 24, 2016 | A | 202,247 | A | Oct 24, 2016 | Oct 24, 2026 | Common Stock | 202,247 | 202,247 | D |